ES2095899T3 - Peptidos de la proteina gag de vih, su preparacion y uso. - Google Patents

Peptidos de la proteina gag de vih, su preparacion y uso.

Info

Publication number
ES2095899T3
ES2095899T3 ES91121362T ES91121362T ES2095899T3 ES 2095899 T3 ES2095899 T3 ES 2095899T3 ES 91121362 T ES91121362 T ES 91121362T ES 91121362 T ES91121362 T ES 91121362T ES 2095899 T3 ES2095899 T3 ES 2095899T3
Authority
ES
Spain
Prior art keywords
preparation
gag protein
hiv gag
protein peptides
hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91121362T
Other languages
English (en)
Inventor
Matthias Dr Niedrig
Susanne Dr Modrow
Hans Prof Dr Wolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Application granted granted Critical
Publication of ES2095899T3 publication Critical patent/ES2095899T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
    • C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA INVENCION SE REFIERE A CIERTOS PEPTIDOS DE LA PROTEINA DEL HIV-GAG Y DERIVADOS DE ESTOS, LOS CUALES NO TENGAN MAS DE 50 AMINOACIDOS Y CONTENGAN AL MENOS UNA DE ESTAS DOS SECUENCIAS PEPTIDICAS: NPGLLETSEGCRQ Y AATLEEMTA.
ES91121362T 1990-12-14 1991-12-12 Peptidos de la proteina gag de vih, su preparacion y uso. Expired - Lifetime ES2095899T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4039925A DE4039925A1 (de) 1990-12-14 1990-12-14 Ausgewaehlte peptide des gruppenspezifischen antigens (gag) von humanem immundefizienzvirus (hiv), ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
ES2095899T3 true ES2095899T3 (es) 1997-03-01

Family

ID=6420301

Family Applications (2)

Application Number Title Priority Date Filing Date
ES96100385T Expired - Lifetime ES2176363T3 (es) 1990-12-14 1991-12-12 Peptidos de la proteina gag del vih, su preparacion y su uso.
ES91121362T Expired - Lifetime ES2095899T3 (es) 1990-12-14 1991-12-12 Peptidos de la proteina gag de vih, su preparacion y uso.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES96100385T Expired - Lifetime ES2176363T3 (es) 1990-12-14 1991-12-12 Peptidos de la proteina gag del vih, su preparacion y su uso.

Country Status (12)

Country Link
US (1) US5612453A (es)
EP (2) EP0490383B1 (es)
JP (2) JP3369585B2 (es)
KR (1) KR920012114A (es)
AT (2) ATE143974T1 (es)
AU (1) AU661464B2 (es)
CA (1) CA2057612C (es)
DE (3) DE4039925A1 (es)
DK (2) DK0490383T3 (es)
ES (2) ES2176363T3 (es)
IE (1) IE914353A1 (es)
PT (1) PT99791B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA903492B (en) * 1989-05-15 1991-02-27 Akzo Nv T-lymphotropic retrovirus monoclonal antibodies
US6426412B1 (en) * 1995-12-20 2002-07-30 Subsidiary No. 3, Inc. Nucleic acids encoding human immunodeficiency virus type 1 genetic suppressor elements
GB9703802D0 (en) * 1997-02-24 1997-04-16 Kingsman Susan M Anti-hiv peptides and proteins
NO314588B1 (no) * 2000-09-04 2003-04-14 Bionor Immuno As HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV
US6818392B2 (en) 2000-12-06 2004-11-16 Abbott Laboratories Monoclonal antibodies to human immunodeficiency virus and uses thereof
EP1855112A1 (en) * 2006-05-10 2007-11-14 Inserm Method for the in vitro screening of compounds inhibiting production of infectious HIV-1 virions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3672624D1 (de) * 1985-02-05 1990-08-23 Us Commerce Verfahren zum nachweis von htlv-iii neutralisierenden antikoerpern in sera.
WO1986006414A1 (en) * 1985-04-29 1986-11-06 Genetic Systems Corporation Synthetic antigens for the detection of aids-related disease
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
CA1339363C (en) * 1987-05-01 1997-08-26 Alan Ray Flesher Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
EP0356007A3 (en) * 1988-07-22 1991-07-03 Medical Research Council Antigenic determinants
FR2640877A1 (es) * 1988-12-06 1990-06-29 Centre Nat Rech Scient
ATE135113T1 (de) * 1988-12-20 1996-03-15 Clarity Technologies Inc Synthetische hiv ähnliche peptide, deren zusammensetzungen und verwendungen
GB8910145D0 (en) * 1989-05-03 1989-06-21 Connaught Lab Synthetic peptides for an hiv-1 vaccine
NZ235538A (en) * 1989-10-12 1992-06-25 Viral Technologies Inc Peptides immunoreactive with antibodies to hiv p17; carrier-bound peptides, vaccines, immunoassay and a method for forming antibody enriched sera
EP0510054A1 (en) * 1990-01-05 1992-10-28 United Biomedical, Inc. Hiv-1 core protein fragments
SE468168B (sv) * 1990-02-20 1992-11-16 Replico Medical Ab Hiv-1, p24 peptider, diagnostiska antigener och foerfarande foer saerskiljande diagnostik av preliminaert hiv-1 positiva serumprov

Also Published As

Publication number Publication date
DE59108261D1 (de) 1996-11-14
AU8976691A (en) 1992-06-18
DK0732339T3 (da) 2002-08-19
DK0490383T3 (da) 1997-02-17
EP0732339A1 (de) 1996-09-18
ATE216706T1 (de) 2002-05-15
KR920012114A (ko) 1992-07-25
PT99791B (pt) 1999-05-31
EP0490383A2 (de) 1992-06-17
DE4039925A1 (de) 1992-06-17
EP0490383B1 (de) 1996-10-09
EP0732339B1 (de) 2002-04-24
US5612453A (en) 1997-03-18
ES2176363T3 (es) 2002-12-01
PT99791A (pt) 1992-12-31
DE59109235D1 (de) 2002-05-29
ATE143974T1 (de) 1996-10-15
JP3369585B2 (ja) 2003-01-20
JP2003176299A (ja) 2003-06-24
EP0490383A3 (en) 1993-06-30
AU661464B2 (en) 1995-07-27
IE914353A1 (en) 1992-06-17
CA2057612A1 (en) 1992-06-15
CA2057612C (en) 2002-02-05
JPH06107697A (ja) 1994-04-19

Similar Documents

Publication Publication Date Title
PE43298A1 (es) Genes sinteticos de vih
CY1110927T1 (el) Αμινο-καταληκτικως διακλαδισμενη rantεs ως ανταγωνιστης των χημοκινων
ES2105924B1 (es) Derivados de indol.
ATE144143T1 (de) Künstlicher impfstoff gegen aids-virus
PT774971E (pt) Inibidores peptidicos sinteticos da transmissao do vih
BR9609795A (pt) Derivados de ciclosporina tendo um efeito anti-hiv
ES2192620T3 (es) Polipeptido receptor de il-13.
ATE141946T1 (de) Hiv-2-virusvarianten
AR247590A1 (es) Una secuencia de adn que codifica derivados de factor viii humano recombinante y un procedimiento para su obtencion
NO912825L (no) Fremgangsmaate for fremstilling av kokonjugatvaksiner omfattende im munogent protein, hiv-beslektede peptider og anioniske grupper.
DE69636285D1 (de) ISOLIERTES FrpB NUKLEINSÄUREMOLEKÜL UND ENTSPRECHENDE IMPFSTOFF
ATE175119T1 (de) Vakzine gegen immunodefizienz-virus der katze (kiv)
ES2180948T3 (es) Peptido que proviene de una forma soluble de la acetilcolinesterasa, activo como modulador del canal.
RU96116005A (ru) Штамм hominis immunodeficiti virus (hiv-i) вич-i/россия/гм-12-95 (ru1295) субтипа в для диагностических и вакцинных препаратов
ATE102217T1 (de) Synthetisches peptid fuer einen hiv-1 impfstoff.
ES2095899T3 (es) Peptidos de la proteina gag de vih, su preparacion y uso.
HUP9801572A2 (hu) Chlamydia-vakcinák
NO904292D0 (no) Fremgangsmaate for fremstilling av antikoagulerende peptider.
IT1249684B (it) Epitopi della proteina env del virus dell'epatite c.
ES2087311T3 (es) Peptidos inductores de anticuerpos que inhiben los retrovirus del tipo hiv y anticuerpos dirigidos contra tales peptidos.
ES2057579T3 (es) Peptidos e1 y c de rubeola.
ES2118131T3 (es) Polipeptidos derivados de la proteina endonucleasa del virus de la inmunodeficiencia adquirida humana.
ES2071038T3 (es) Peptidos asociados al hiv.
DE69122103D1 (de) Antigerinnungspeptide
ES2080193T3 (es) Anticuerpos monoclonales contra la gp120 de vih.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 490383

Country of ref document: ES